Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)

Clinical trial NCT00322361 · COMPLETED

Trial details

NCT number: NCT00322361
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis B Hepatocellular Carcinoma

Start date: 2006-05-01
Primary completion: 2007-07-01
Enrollment: 566

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.